Eagle Veterinary Technology Co.,Ltd (KOSDAQ:044960)
3,145.00
+10.00 (0.32%)
At close: Sep 11, 2026
KOSDAQ:044960 Revenue
Eagle Veterinary Technology Co.,Ltd had revenue of 12.15B KRW in the quarter ending June 30, 2026, with 10.16% growth. This brings the company's revenue in the last twelve months to 44.73B, up 6.68% year-over-year. In the year 2025, Eagle Veterinary Technology Co.,Ltd had annual revenue of 43.32B with 3.85% growth.
Revenue (ttm)
44.73B
Revenue Growth
+6.68%
P/S Ratio
0.89
Revenue / Employee
688.16M
Employees
65
Market Cap
39.76B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.32B | 1.61B | 3.85% |
| Dec 31, 2024 | 41.72B | -1.08B | -2.52% |
| Dec 31, 2023 | 42.79B | -746.00M | -1.71% |
| Dec 31, 2022 | 43.54B | 3.10B | 7.67% |
| Dec 31, 2021 | 40.44B | 80.27M | 0.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 195.70B |
| RP Bio | 141.42B |
| Jin Yang Pharmaceutical | 124.61B |
| Hwail Pharmaceutical | 107.87B |
| GeneBioTech Co. ,Ltd | 89.31B |
| Korean Drug | 65.39B |
| Kyung Nam Pharm | 54.89B |
| Pharmsville | 11.20B |